Veterinary Drugs
Medicinal products for animals, including pharmaceuticals and biologicals, subject to authorisation, maximum residue limits (MRLs) in food of animal origin, and environmental impact assessments.
Foresight tracks Veterinary Drugs developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Current activity
Cooling
30% below the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
9 April 2026, 10:23
Latest Veterinary Drugs alerts
The most recent regulatory and guidance signals tracked by Foresight
Missouri House Schedules Nuclear Clean Power, Paint Recycling And Xylazine Bills For Floor Consideration
Missouri advances legislation establishing a statewide paint recycling program, nuclear energy cost-recovery, and stricter controls on xylazine (April 2026). Companies should prepare for new producer responsibility obligations in the coatings sector and evolving regulatory frameworks for clean energy and controlled substances.
Ukraine Proposes Regulation On State Registration Of Veterinary Medicinal Products
Ukraine has proposed a new registration framework for veterinary medicinal products to align its market access standards with EU Regulation 2019/6. Companies must prepare for rigorous dossier, labeling, and GMP compliance requirements, with phased implementation deadlines beginning in 2026.
Netherlands CBB Confirms Halved Fine for Dairy Farm’s Veterinary Withdrawal-Period Breach (ECLI:NL:CBB:2026:134)
The Dutch CBB confirmed a reduced €2,500 fine for a dairy farm's failure to observe the mandatory 15-day withdrawal period for a veterinary medicine before slaughter. The decision underscores strict liability for food chain documentation while establishing a precedent for proportionate penalty reductions in cases of isolated administrative errors.
Switzerland OSAV Temporarily Authorises Import and Marketing of Bovilis Lumpyvax‑E Lumpy Skin Disease Vaccine
Switzerland has granted temporary market access for the Bovilis Lumpyvax-E vaccine through June 2027 to address Lumpy Skin Disease risks. Companies must navigate rigorous batch-specific approvals and GMP standards, signaling a prioritized but strictly regulated emergency procurement pathway for veterinary products.
Missouri House Advances Bill Adding Xylazine to Schedule III Controlled Substances
Missouri is advancing legislation to schedule xylazine as a controlled substance and tighten permits for invasive plants, with key changes expected by August 2026. Businesses must prepare for increased regulatory oversight on veterinary drugs and stricter affidavit requirements for seed and plant sales.
EU Commission Extends Transitional Period and Sampling Rules Under Implementing Regulation (EU) 2021/808 (Regulation (EU) 2026/731)
The EU has extended the transitional period for legacy residue analytical methods until December 31, 2027, while updating sampling protocols for animal products and feed. This extension allows laboratories more time to align with modern validation standards, ensuring continued compliance and consistency in food safety enforcement.
EU Implementing Regulation 2026/731 Extends Residues Methods Transitional Period and Updates Sampling Under Regulation 2021/808
The EU has extended the transitional period for laboratories to adopt updated residue analysis methods for pharmacologically active substances until 31 December 2027. This extension provides critical operational relief for food safety testing facilities, allowing more time to align validation protocols with EU official control standards without disrupting market access.
EU Council Presidency Suggests Amendments to Organic Production Regulation on Imports, Logo Use and Certification
The EU Council Presidency has proposed amendments to the Organic Production Regulation, extending third-country equivalence to 2036 and revising EU logo rules for imported ingredients. This shift requires supply chain adjustments for processed goods using imported organic components while offering operational relief through simplified certification and broader access to cleaning agents.
Denmark Announces 2026 Medicine-Control Inspections in Pig Herds Focusing on Antibiotic Use
Denmark will conduct targeted inspections of pig herds starting April 2026 to enforce strict antibiotic stewardship and record-keeping compliance. Agricultural operators must prioritize biosecurity and veterinary documentation to mitigate enforcement risks as authorities crack down on routine antimicrobial use.
UK Government Written Answer on Environmental Quality Standards for Fipronil and Imidacloprid
UK Government confirms that future Environmental Quality Standards (EQS) for fipronil and imidacloprid will be integrated into broader water quality reforms and pharmaceutical roadmaps. Companies should anticipate stricter aquatic toxicity targets and potential priority substance designations as part of the upcoming "once in a generation" water policy overhaul.
Welsh Study Finds Veterinary Ectoparasiticides (Imidacloprid, Fipronil and Diazinon) Above Safe Levels in Rivers
A new study reveals that veterinary pesticides from pet treatments and sheep dips are contaminating Welsh rivers at levels significantly exceeding safety thresholds. This evidence increases regulatory pressure on pet care product authorizations and wastewater management, signaling potential future restrictions on "down-the-drain" chemical pathways.
Honduras ARSA Updates Controlled Substances And Precursors List And Strengthens Control Regime
Honduras updated its controlled substances and precursors list on 24 February 2026, introducing immediate reporting obligations and new equipment import controls effective 10 April 2026. Companies must audit product compositions against new concentration thresholds and secure specialized equipment permits to ensure uninterrupted manufacturing and distribution operations.
EDQM European Pharmacopoeia Commission Adopts 50 Texts for Ph. Eur. Issue 13.2
The European Pharmacopoeia Commission has adopted 50 new and revised texts for Issue 13.2, set to become legally binding on April 1, 2027. Pharmaceutical manufacturers must assess impacts on quality control specifications, particularly for elemental analysis and glass packaging, to ensure compliance before the implementation deadline.
Minnesota SF 4561 Agriculture Omnibus Would Update Compost, Plant Biostimulant, Cell-Cultured Food and Veterinary Drug Rules
Minnesota is advancing an omnibus bill (SF 4561) to update regulatory definitions for plant biostimulants, fertilizers, and cell-cultured food labeling by mid-2026. Impacted businesses must prepare for new labeling mandates for novel foods and stricter permitting and record-keeping requirements for agricultural inputs and veterinary pharmaceuticals.
France / ANMV Issues February 2026 Veterinary Medicinal Product Decisions and Highlights Duck Vaccination and VICH GL9 Activities
France’s ANMV has issued its February 2026 veterinary medicinal product decisions and updated its strategy for mandatory avian influenza vaccination and clinical trial harmonization. Stakeholders must assess specific marketing authorization modifications and prepare for increased European alignment in clinical trial inspections under the VICH GL9 framework.
USDA AMS Proposes National Organic Program National List Changes for Carbon Dioxide, Sodium Nitrate, Meloxicam and Methionine
The USDA is proposing to update the National Organic Program's National List to allow or renew the use of specific substances, including carbon dioxide, sodium nitrate, and meloxicam, with comments due by May 22, 2026. This update modernizes organic production by expanding tools for pest management and animal welfare while streamlining compliance for poultry producers through the removal of specific nutrient limits.
Estonian Agency of Medicines Announces 31 March Info Day for Marketing Authorisation Holders
The Estonian Agency of Medicines is hosting a March 2026 briefing for marketing authorisation holders on EU pharmaceutical law reforms and supply shortage management. Companies should use this session to align their compliance strategies with upcoming EU regulatory shifts and national procedural updates for medicinal products.
Estonia (Ravimiamet) Reports 50% Reduction in Veterinary Antibiotic Use Since 2014
Estonia has halved veterinary antibiotic use since 2014, effectively reaching the scale of EU 2030 reduction targets years in advance. This progress signals a mature regulatory environment for antimicrobial stewardship, likely leading to sustained pressure on the animal health sector to maintain low usage levels.
European Commission Issues Guidance On Evaluating Feed Homogeneity And Cross-Contamination
The European Commission has issued detailed guidance (March 2026) for national authorities on evaluating feed homogeneity and cross-contamination controls under EU feed hygiene and medicated feed regulations. Feed business operators should align internal testing protocols and documentation with the Commission's new statistical benchmarks and frequency recommendations to ensure compliance during future regulatory audits and official controls.
UK Explanatory Memorandum On EU Proposal To Amend Organic Production Rules (COM(2025)780)
The EU has proposed significant amendments to the Organic Production Regulation, including a 10-year extension for third-country equivalence regimes and the removal of restrictive 'positive lists' for cleaning and disinfection products. These changes aim to prevent trade disruption through 2036 while reducing administrative burdens for operators and aligning veterinary medicine withdrawal periods with broader EU standards.
Related topics
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Veterinary Drugs alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Book a demoFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at